Ten-year trends in quality of care and spending for depression: 1996 Through 2005

Archives of General Psychiatry

Volumn 68, Issue 12, 2011, Pages 1218-1226

  Fullerton, Catherine A ^a,c   Busch, Alisa B ^a,d   Normand, Sharon Lise T ^a,b   McGuire, Thomas G ^a   Epstein, Arnold M ^a,b,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Cambridge Health Alliance ^*  (United States)

^d MCLEAN HOSPITAL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DEPRESSION; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL HEALTH CARE; PSYCHOTHERAPY; SUICIDAL BEHAVIOR;

ADOLESCENT; ADULT; DEPRESSIVE DISORDER; FEMALE; FLORIDA; HEALTH EXPENDITURES; HUMANS; MALE; MEDICAID; MENTAL HEALTH SERVICES; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; UNITED STATES; YOUNG ADULT;

EID: 83055171497     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.146     Document Type: Article

References (64)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. (Pubitemid 40973434)
2. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press; 1996.
3. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262(7):914-919. (Pubitemid 19208948)
4. Druss BG, Rosenheck RA, Sledge WH. Health and disability costs of depressive illness in a major U.S. corporation. Am J Psychiatry. 2000;157(8):1274-1278. (Pubitemid 30659810)
5. Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995;52(10):850-856.
6. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA. 1990;264 (19):2524-2528.
7. Berndt ER, Koran LM, Finkelstein SN, Gelenberg AJ, Kornstein SG, Miller IM, Thase ME, Trapp GA, Keller MB. Lost human capital from early-onset chronic depression. Am J Psychiatry. 2000;157(6):940-947. (Pubitemid 30412345)
8. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135- 3144.
9. Bruce ML, Leaf PJ, Rozal GP, Florio L, Hoff RA. Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am J Psychiatry. 1994;151(5):716-721. (Pubitemid 24140561)
10. Olfson M, Marcus SC, Druss BG, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA. 2002;287(2):203-209. (Pubitemid 34251945)
11. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465- 1475.
12. Wang PS, Demler O, Olfson M, Pincus HA, Wells KB, Kessler RC. Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry. 2006;163(7):1187-1198. (Pubitemid 44464446)
13. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58(1): 55-61. (Pubitemid 32057765)
14. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629-640. (Pubitemid 40973438)
15. Charbonneau A, Rosen AK, Ash AS, Owen RR, Kader B, Spiro A III, Hankin C, Herz LR, Pugh MJV, Kazis L, Miller DR, Berlowitz DR. Measuring the quality of depression care in a large integrated health system. Med Care. 2003;41(5): 669-680.
16. Chen Y, Kelton CM, Jing Y, Guo JJ, Li X, Patel NC. Utilization, price, and spending trends for antidepressants in the US Medicaid program. Res Social Adm Pharm. 2008;4(3):244-257.
17. Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 2004;42(12):1176-1185. (Pubitemid 39627294)
18. Libby AM, Orton HD, Valuck RJ. Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry. 2009;66(6):633-639.
19. Centers for Medicare and Medicaid Services, Office of Research Development and Information, Mathematica Policy Research. The Medicaid Analytic eXtract (MAX) Chartbook. https://www.cms.gov/medicaiddatasourcesgeninfo/07- maxgeneralinformation.asp. Accessed September 8, 2011.
20. Kniesner TJ, Powers RH, Croghan TW. Provider type and depression treatment adequacy. Health Policy. 2005;72(3):321-332. (Pubitemid 40614683)
21. Katon WJ, Richardson L, Russo J, Lozano P, McCauley E. Quality of mental health care for youth with asthma and comorbid anxiety and depression. Med Care. 2006; 44(12):1064-1072. (Pubitemid 44808666)
22. Sewitch MJ, Blais R, Rahme E, Bexton B, Galarneau S. Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use. Can J Psychiatry. 2007;52(3):191-200. (Pubitemid 46761965)
23. Busch AB, Huskamp HA, Normand SL, Young AS, Goldman HH, Frank RG. The impact of parity on major depression treatment quality in the Federal Employees'Health Benefits Program after parity implementation. Med Care. 2006; 44(6):506-512. (Pubitemid 44284289)
24. Spettell CM, Wall TC, Allison J, Calhoun J, Kobylinski R, Fargason R, Kiefe CI. Identifying physician-recognized depression from administrative data: consequences for quality measurement. Health Serv Res. 2003;38(4):1081-1102. (Pubitemid 37048301)
25. Arday SL, Arday DR, Monroe S, Zhang J. HCFA's racial and ethnic data: current accuracy and recent improvements. Health Care Financ Rev. 2000;21(4):107-116.
26. Scott CG. Identifying the race or ethnicity of SSI recipients. Soc Secur Bull. 1999; 62(4):9-20.
27. Fochtmann IJ, Gelenberg AJ. Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder. 2nd ed. Arlington, VA: American Pyshicatric Association; 2005.
28. Charbonneau A, Rosen AK, Owen RR, Spiro A III, Ash AS, Miller DR, Kazis L, Kader B, Cunningham F, Berlowitz DR. Monitoring depression care: in search of an accurate quality indicator. Med Care. 2004;42(6):522-531.
29. Rost K, Dickinson LM, Fortney JC, Westfall J, Hermann RC. Clinical improvement associated with conformance to HEDIS-based depression care. Ment Health Serv Res. 2005;7(2):103-112. (Pubitemid 40762550)
30. Wells KB, Sturm R. Care for depression in a changing environment. Health Aff (Millwood). 1995;14(3):78-89.
31. Schoenbaum M, Unützer J, McCaffrey D, Duan N, Sherbourne C, Wells KB. The effects of primary care depression treatment on patients' clinical status and employment. Health Serv Res. 2002;37(5):1145-1158. (Pubitemid 35398453)
32. Katon WJ, Simon GE, Russo J, Von Korff M, Lin EHB, Ludman E, Ciechanowski P, Bush T. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care. 2004;42(12):1222-1229. (Pubitemid 39627299)
33. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121-130.
34. US Census Bureau. Current Population Survey table creator. http://www.census.gov/hhes/www/cpstc/cps-table-creator.html. Accessed October 5, 2010.
35. US Census Bureau. Population estimates for states by race and Hispanic origin: July 1, 1996. http://www.census.gov/popest/archives/1990s/strh/srh96. txt. Accessed October 5, 2010.
36. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157 (4)(suppl):1-45.
37. Labbate LA, Fava M, Rosenbaum JF, Arana GW. Handbook of Psychiatric Drug Therapy. 6th ed. New York, NY: Lippincott, Williams & Wilkins; 2009.
38. Leslie DL, Mohamed S, Rosenheck RA. Off-label use of antipsychotic medications in the Department of Veterans Affairs health care system. Psychiatr Serv. 2009;60(9):1175-1181.
39. Philip NS, Mello K, Carpenter LL, Tyrka AR, Price LH. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Ann Clin Psychiatry. 2008;20(1):15-20. (Pubitemid 351302398)
40. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf. 2011;20(2):177-184.
41. Newcomer JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry. 2007;68(suppl 1):20-27.
42. Landon BE, Schneider EC, Normand SL, Scholle SH, Pawlson LG, Epstein AM. Quality of care in Medicaid managed care and commercial health plans. JAMA. 2007;298(14):1674-1681. (Pubitemid 47606656)
43. Druss BG, Bradford WD, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry. 2001;58(6):565-572. (Pubitemid 32523736)
44. Drake R, Skinner J, Goldman HH. What explains the diffusion of treatments for mental illness? Am J Psychiatry. 2008;165(11):1385-1392.
45. Kadam UT, Croft P, McLeod J, Hutchinson M. A qualitative study of patients' views on anxiety and depression. Br J Gen Pract. 2001;51(466):375-380. (Pubitemid 32421782)
46. Zivin K, Kales HC. Adherence to depression treatment in older adults: a narrative review. Drugs Aging. 2008;25(7):559-571. (Pubitemid 351918799)
47. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314-2321. (Pubitemid 44833355)
48. Katon WJ, Zatzick D, Bond G, Williams J Jr. Dissemination of evidence-based mental health interventions: importance to the trauma field. J Trauma Stress. 2006;19(5):611-623. (Pubitemid 46424376)
49. Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database [published correction appears in BMJ. 2009;339:b4361]. BMJ. 2009;339:b3999. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2762496 /?tool=pubmed. Accessed September 6, 2011.
50. Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry. 2010;67(12):1265-1273.
51. Frank RG, Goldman HH, McGuire TG. Trends in mental health cost growth: an expanded role for management? Health Aff (Millwood). 2009;28(3):649-659.
52. Mark TL, Levit KR, Buck JA, Coffey RM, Vandivort-Warren R. Mental health treatment expenditure trends, 1986-2003. Psychiatr Serv. 2007;58(8):1041-1048. (Pubitemid 47290861)
53. Harman JS, Edlund MJ, Fortney JC. Trends in antidepressant utilization from 2001 to 2004. Psychiatr Serv. 2009;60(5):611-616.
54. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8):848-856.
55. Cully JA, Zimmer M, Khan MM, Petersen LA. Quality of depression care and its impact on health service use and mortality among veterans. Psychiatr Serv. 2008; 59(12):1399-1405.
56. National Committee for Quality Assurance. The State of Health Care Quality, 2009. Washington, DC: NCQA; 2009.
57. National Committee for Quality Assurance. The State of Health Care Quality, 2003. Washington, DC: NCQA; 2003.
58. Busch AB, Ling DC, Frank RG, Greenfield SF. Changes in the quality of care for bipolar I disorder during the 1990s. Psychiatr Serv. 2007;58(1):27-33.
59. Busch AB, Lehman AF, Goldman HH, Frank RG. Changes over time and disparities in schizophrenia treatment quality. Med Care. 2009;47(2):199-207.
60. Zuvekas SH. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001. Health Aff (Millwood). 2005;24(1):195-205. (Pubitemid 40169788)
61. Gibson TB, Lee TA, Vogeli CS, Hidalgo J, Carls GS, Sredl K, DesHarnais S, Marder WD, Weiss KB, Williams TV, Shields AE. A four-system comparison of patients with chronic illness: the Military Health System, Veterans Health Administration, Medicaid, and commercial plans. Mil Med. 2009;174(9):936-943.
62. Domino ME, Swartz MS. Who are the new users of antipsychotic medications? Psychiatr Serv. 2008;59(5):507-514.
63. Mark TL, Levit KR, Vandivort-Warren R, Buck JA, Coffey RM. Changes in US spending on mental health and substance abuse treatment, 1996-2005, and implications for policy. Health Aff (Millwood). 2011;30(2):284-292.
64. Foster RS. Estimated Financial Effects of the "Patient Protection and Affordability Care Act" as Amended. Baltimore, MD: Dept of Health and Human Services; April 22, 2010.